Evolus
EOLS
#7676
Rank
S$0.59 B
Marketcap
S$8.96
Share price
-3.06%
Change (1 day)
-0.65%
Change (1 year)

Earnings for Evolus (EOLS)

Earnings in 2026 (TTM): -S$38.97 Million

According to Evolus 's latest financial reports the company's current earnings are S$0.32 Billion. In 2025 the company made an earning of -S$65.65 Million a decrease over its 2024 earnings that were of -S$64.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Evolus from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$38.97 Million-40.64%
2025 -S$65.65 Million2.43%
2024 -S$64.09 Million-19.11%
2023 -S$79.23 Million-17.23%
2022 -S$95.73 Million59.02%
2021 -S$60.2 Million-71.32%
2020 -S$0.21 Billion55.09%
2019 -S$0.14 Billion124.48%
2018 -S$60.29 Million298.96%
2017 -S$15.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.21 Billion 414.62%๐Ÿ‡บ๐Ÿ‡ธ USA